Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Department of General, Visceral and Vascular Surgery, Centre for Hepatobiliary Surgery, Vöcklabruck, Austria.
Br J Surg. 2023 Sep 6;110(10):1331-1347. doi: 10.1093/bjs/znad233.
Posthepatectomy liver failure (PHLF) contributes significantly to morbidity and mortality after liver surgery. Standardized assessment of preoperative liver function is crucial to identify patients at risk. These European consensus guidelines provide guidance for preoperative patient assessment.
A modified Delphi approach was used to achieve consensus. The expert panel consisted of hepatobiliary surgeons, radiologists, nuclear medicine specialists, and hepatologists. The guideline process was supervised by a methodologist and reviewed by a patient representative. A systematic literature search was performed in PubMed/MEDLINE, the Cochrane library, and the WHO International Clinical Trials Registry. Evidence assessment and statement development followed Scottish Intercollegiate Guidelines Network methodology.
Based on 271 publications covering 4 key areas, 21 statements (at least 85 per cent agreement) were produced (median level of evidence 2- to 2+). Only a few systematic reviews (2++) and one RCT (1+) were identified. Preoperative liver function assessment should be considered before complex resections, and in patients with suspected or known underlying liver disease, or chemotherapy-associated or drug-induced liver injury. Clinical assessment and blood-based scores reflecting liver function or portal hypertension (for example albumin/bilirubin, platelet count) aid in identifying risk of PHLF. Volumetry of the future liver remnant represents the foundation for assessment, and can be combined with indocyanine green clearance or LiMAx® according to local expertise and availability. Functional MRI and liver scintigraphy are alternatives, combining FLR volume and function in one examination.
These guidelines reflect established methods to assess preoperative liver function and PHLF risk, and have uncovered evidence gaps of interest for future research.
肝切除术后肝功能衰竭(PHLF)是肝手术后发病率和死亡率升高的主要原因。对术前肝功能进行标准化评估对于识别高危患者至关重要。这些欧洲共识指南为术前患者评估提供了指导。
采用改良 Delphi 方法达成共识。专家小组由肝胆外科医生、放射科医生、核医学专家和肝病专家组成。指南制定过程由一名方法学家监督,并由一名患者代表进行审查。在 PubMed/MEDLINE、Cochrane 图书馆和世界卫生组织国际临床试验注册平台进行了系统的文献检索。证据评估和声明制定遵循苏格兰校际指南网络方法。
基于涵盖 4 个关键领域的 271 篇出版物,提出了 21 项声明(至少 85%的专家达成一致意见)(中位数证据水平为 2-2+)。仅确定了少数系统评价(2++)和一项 RCT(1+)。复杂切除术、疑似或已知潜在肝病患者、化疗相关或药物性肝损伤患者应考虑术前肝功能评估。临床评估和反映肝功能或门脉高压的血液评分(如白蛋白/胆红素、血小板计数)有助于识别 PHLF 风险。未来肝残留量的体积测量是评估的基础,可根据当地专业知识和可用性与吲哚菁绿清除率或 LiMAx®相结合。功能 MRI 和肝脏闪烁显像术是替代方法,可在一次检查中结合 FLR 体积和功能。
这些指南反映了评估术前肝功能和 PHLF 风险的既定方法,并揭示了未来研究中感兴趣的证据空白。